Pharma Focus Asia

Eli Lilly Invests US$1 billion to Open New Manufcaturing Facility

Introduction:

Eli Lilly plans for the construction of new manufacturing site. The new site will be located in North California.

Features:

The new facility will be designed with latest technologies to manufacture  parenteral (injectable) products and devices including medicines.

The manufacuturing facility enables to produce today's medicinesand on the other hand, additional capacity will be dedicated for the manufacturingof medicines infuture. In addition, the facility benefits the people around the globe by providing more medicinesto address health challenges.

The construction of the new facility strengthens relationships with local governments and universities and expand its growing presence in the state.

The facility is expected to create approximately 600 new jobs for highly skilled workers such as scientists, engineers and manufacturing personnel. Moreover, additional 500 positions will be neededduring construction.

Specifications:

NameEli Lilly and Company
TypeNew Construction
BudgetUS$1 billion
Year2022
magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024